Company Overview of Oncopeptides AB
Oncopeptides AB is a clinical stage pharmaceutical development company that develops cytosuperior chemotherapeutic pharmaceuticals of existing basic cytotoxic compounds for cancer treatment. Its product includes Melflufen, a cytosuperior of the chemotherapeutic alkylator melphalan that is accumulated in cancer cells for targeting multiple myeloma. The company is headquartered in Stockholm, Sweden.
Västra Trädgårdsgatan 15
Stockholm, 111 53
46 7 05 69 54 71
Key Executives for Oncopeptides AB
Oncopeptides AB Key Developments
Similar Private Companies By Industry
|Glucox Biotech AB||Europe|
|Allergan Norden AB||Europe|
|Cambrex Karlskoga AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Oncopeptides AB, please visit www.oncopeptides.se. Company data is provided by Capital IQ. Please use this form to report any data issues.